Join the National Foundation for Infectious Diseases (NFID) for a discussion on recent updates in respiratory syncytial virus (RSV) prevention and current immunization recommendations. Speakers address current US recommendations for vaccines and monoclonal antibodies to help prevent RSV across the lifespan, as well as implementation strategies.
In this recorded webinar, NFID Medical Director Robert H. Hopkins, Jr., MD, moderates the discussion with presentations by Jefferson Jones, MD, MPH, Medical Officer, Centers for Disease Control and Prevention (CDC), and NFID Director Flor M. Muñoz, MD, MSc, Associate Professor of Pediatrics, Baylor College of Medicine. Jennifer DeCuir, MD, PhD, Medical Officer, Centers for Disease Control and Prevention (CDC), also participated to address audience questions regarding current recommendations.
At the conclusion of this activity, participants will be able to:
- Describe the burden of RSV in the US and the disproportionate impact on communities of color
- Describe updates to ACIP recommendations for RSV prevention
- Identify strategies for implementation of US recommendations for RSV prevention into practice
There is no fee to participate in this activity, but pre-registration is required: https://nfid.app.neoncrm.com/np/clients/nfid/eventRegistration.jsp?event=522&
The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.